Login / Signup

Challenges and perspectives of selenium supplementation in Graves' disease and orbitopathy.

Tomasz BednarczukLutz Schomburg
Published in: Hormones (Athens, Greece) (2019)
Additional randomized clinical trials with clinically relevant endpoints are urgently needed to further aid in clinical decision-making, including better stratification of Graves' disease patients, who are most likely to benefit from Se supplementation.
Keyphrases
  • decision making
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • clinical trial